English EN Spanish ES French FR Chinese (Simplified) ZH-CN
Print Friendly, PDF & Email

NCT/Study#

NCT03424005 /

CO40115 - Morpheus TNBC

A Phase Ib/Ii,Open-Label, Multicenter, Randomized Umbrella Study Evaluating The Efficacy And Safety Of Multiple Immunotherapy-Based Treatment Combinations In Patients With Metastatic Triple-Negative Breast Cancer (Morpheus-Tnbc)

DISEASE GROUP:
Breast Cancer Clinical Trials
current phase:
Ib/II
STUDY STATUS:
Accepting Patients
Location:
Howell, NJ
For More information: